Valuence Merger I filed to offer 20 million units at $10 each. A unit consists of one Class A ordinary share and one-half of a warrant.
Valuence will pursue an acquisition of a life sciences company baxsed in Asia, excluding China, Hong Kong and Macau.
CEO and Director Sung Yoon Woo is the founder and CEO of Credian Partners, a private equity firm based in South Korea.
SVB Leerlink is sole book-running manager. Baird is lead manager on the deal.
The SPAC has applied to list on the Nasdaq under the symbol VMCAU. Read more.
